NOVATO, Calif., May 14, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), announced that NASDAQ is adding Raptor to the NASDAQ Biotechnology Index (NASDAQ: NBI and XNBI). The NBI includes seasoned NASDAQ Global Market and Global Select issuers classified as biotech or pharmaceutical companies with a minimum market capitalization of $200 million, minimum daily trading volume of 100,000 shares and other eligibility requirements. More information on the index is available on NASDAQ's website at:
